The diagnostic and molecular characteristics of malignant mesothelioma and ovarian/peritoneal serous carcinoma

被引:33
作者
Davidson, B. [1 ,2 ]
机构
[1] Oslo Univ Hosp, Dept Pathol, Norwegian Radium Hosp, Div Pathol, N-0310 Oslo, Norway
[2] Univ Oslo, Fac Med, Oslo, Norway
关键词
cytology; malignant mesothelioma; serous carcinoma; effusion; diagnosis; cancer biology; COMPARATIVE GENOMIC HYBRIDIZATION; EPITHELIAL OVARIAN-CANCER; FOLATE RECEPTOR-ALPHA; PLEURAL MESOTHELIOMA; PERITONEAL MESOTHELIOMA; DIFFERENTIAL-DIAGNOSIS; MONOCLONAL-ANTIBODY; GROWTH-FACTOR; LAMININ RECEPTOR; POOR SURVIVAL;
D O I
10.1111/j.1365-2303.2010.00829.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The diagnostic and molecular characteristics of malignant mesothelioma and ovarian/peritoneal serous carcinoma Malignant mesothelioma and ovarian/peritoneal serous carcinoma are two of the most common tumours affecting the serosal cavities. Unlike other malignant tumours diagnosed at this anatomical site, such as lung and breast carcinoma, malignant mesothelioma and serous carcinoma share a common histogenesis, may be difficult to differentiate morphologically, and co-express many of the diagnostic markers used by cytopathologists in effusion diagnosis. Selected markers have nevertheless shown sufficient sensitivity and specificity to differentiate serous carcinoma from malignant mesothelioma effectively. Recently, our group applied high throughput technology to the identification of new markers that may aid in differentiating these two cancer types and validated several of these markers in follow-up studies. This review will present current data regarding the diagnostic and biological aspects of malignant mesothelioma and ovarian/peritoneal serous carcinoma.
引用
收藏
页码:5 / 21
页数:17
相关论文
共 50 条
  • [41] Targeting microRNA to improve diagnostic and therapeutic approaches for malignant mesothelioma
    Birnie, Kimberly A.
    Prele, Cecilia M.
    Thompson, Philip J.
    Badrian, Bahareh
    Mutsaers, Steven E.
    ONCOTARGET, 2017, 8 (44) : 78193 - 78207
  • [42] Tenascin-X is a Novel Diagnostic Marker of Malignant Mesothelioma
    Yuan, Yuan
    Nymoen, Dag Andre
    Stavnes, Helene Tuft
    Rosnes, Anne Katrine
    Bjorang, Ola
    Wu, Chuanyue
    Nesland, Jahn M.
    Davidson, Ben
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2009, 33 (11) : 1673 - 1682
  • [43] Peritoneal malignant mesothelioma (PMM), and primary peritoneal serous carcinoma (PPSC) and reactive mesothelial hyperplasia (RMH) of the peritoneum. Immunohistochemical and fluorescence in situ hybridisation (FISH) analyses
    Kawai, Toshiaki
    Tominaga, Susumu
    Hiroi, Sadayuki
    Ogata, Sho
    Nakanishi, Kuniaki
    Kawahara, Kunimitsu
    Sonobe, Hiroshi
    Hiroshima, Kenzo
    JOURNAL OF CLINICAL PATHOLOGY, 2016, 69 (08) : 706 - 712
  • [44] Ovarian Low-grade and High-grade Serous Carcinoma Pathogenesis, Clinicopathologic and Molecular Biologic Features, and Diagnostic Problems
    Vang, Russell
    Shih, Ie-Ming
    Kurman, Robert J.
    ADVANCES IN ANATOMIC PATHOLOGY, 2009, 16 (05) : 267 - 282
  • [45] Rare Variants of Malignant Peritoneal Mesothelioma: a Literature Review
    Chatterjee, Ambarish
    Bhatt, Aditi
    INDIAN JOURNAL OF SURGICAL ONCOLOGY, 2023, 14 (SUPPL 1) : 30 - 38
  • [46] Ovarian Serous Tumors of Low Malignant Potential With Nodal Low-grade Serous Carcinoma
    Djordjevic, Bojana
    Malpica, Anais
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2012, 36 (07) : 955 - 963
  • [47] Evaluation of prognostic histological parameters proposed for pleural mesothelioma in diffuse malignant peritoneal mesothelioma. A short report
    Pezzuto, Federica
    Vimercati, Luigi
    Fortarezza, Francesco
    Marzullo, Andrea
    Pennella, Antonio
    Cavone, Domenica
    Punzi, Alessandra
    Caporusso, Concetta
    d'Amati, Antonio
    Lettini, Teresa
    Serio, Gabriella
    DIAGNOSTIC PATHOLOGY, 2021, 16 (01)
  • [48] Diffuse malignant peritoneal mesothelioma: A review
    Sun, Luanbiao
    Li, Chenguang
    Gao, Shuohui
    FRONTIERS IN SURGERY, 2023, 9
  • [49] Mesothelin and osteopontin as circulating markers of diffuse malignant peritoneal mesothelioma: A preliminary study
    Bruno, Federica
    Baratti, Dario
    Martinetti, Antonia
    Morelli, Daniele
    Sottotetti, Elisa
    Bonini, Chiara
    Guaglio, Marcello
    Kusamura, Shigeki
    Deraco, Marcello
    EJSO, 2018, 44 (06): : 792 - 798
  • [50] Malignant peritoneal mesothelioma and Crohn disease
    Butnor, Kelly J.
    Pavlisko, Elizabeth N.
    Sporn, Thomas A.
    Roggli, Victor L.
    JOURNAL OF CLINICAL PATHOLOGY, 2017, 70 (03) : 228 - 232